TY  - JOUR
T1  - DIabetes drug may be associated with increase in risk of bladder cancer
AU  - Stephenson J
Y1  - 2011/07/13
N1  - 10.1001/jama.2011.939
JO  - JAMA
SP  - 143
EP  - 143
VL  - 306
IS  - 2
N2  - 
The FDA is advising health care professionals to not use pioglitazone in patients with active bladder cancer and to prescribe the drug with caution for patients with a prior history of bladder cancer, weighing the benefits of blood glucose control “against the unknown risks for cancer recurrence” (http://tinyurl.com/3owghao).

SN  - 0098-7484
M3  - doi: 10.1001/jama.2011.939
UR  - http://dx.doi.org/10.1001/jama.2011.939
ER  -